Cost-effectiveness analysis of intravenous paricalcitol vs. oral calcitriol in the treatment of hyperparathyroidism secondary to chronic kidney disease. - Cardoso MMA; Machado-Rugolo J; Lima SAM; Andrade LGM; Curado DSP; Ponce D (Jornal brasileiro de nefrologia, 2023)